Activity of larotrectinib in TRK fusion cancer patients with brain metastases or primary central nervous system tumors Meeting Abstract


Authors: Leyvraz, S.; Drilon, A.; Dubois, S. G.; Farago, A. F.; Geoerger, B.; Grilley-Olson, J. E.; Hong, D. S.; Sohal, D.; van Tilburg, C. M.; Ziegler, D. S.; Ku, N. C.; Cox, M. C.; Nanda, S.; Childs, B. H.; Doz, F.
Abstract Title: Activity of larotrectinib in TRK fusion cancer patients with brain metastases or primary central nervous system tumors
Meeting Title: 34. Deutscher Krebskongress (DKK)
Journal Title: Oncology Research and Treatment
Volume: 43
Issue: Suppl. 1
Meeting Dates: 2020 Feb 19-22
Meeting Location: Berlin, Germany
ISSN: 2296-5270
Publisher: S. Karger AG  
Date Published: 2020-02-01
Start Page: 32
Language: English
ACCESSION: WOS:000517158700082
PROVIDER: wos
DOI: 10.1159/000506491
Notes: "34th German Cancer Congress" -- Meeting Abstract: 282 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon